Login

Principia Biopharma Inc. SEC Filings

Filed On Filing
16 Feb 2021 SC 13G/A
08 Oct 2020 15-12B
01 Oct 2020 AMENDMENT TO FORM SC 13D
29 Sep 2020 EFFECT
28 Sep 2020 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
28 Sep 2020 Form 4: Tomasello Shawn, Director

Disposed of 30,715 Director Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Machado Patrick, Director

Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: George Simeon, Director

Disposed of 2,982,855 shares (Tender Offer) ($298M) · Disposed of 28,623 Warrant (Disposition to Issuer) · Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Lin Shao-Lee, Director

Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Becker Daniel J., Director

Disposed of 667,600 shares (Tender Offer) ($66.8M) · Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Colowick Alan, Director

Disposed of 88,679 Director Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Wolff Stefani, Chief Development Officer

Gave 5,504 shares as a gift · Disposed of 13,592 shares (Tender Offer) ($1.36M) · Disposed of 238,958 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Thomas Dolca, Chief Medical Officer

Disposed of 2,207 shares (Tender Offer) ($221K) · Disposed of 283,057 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Hardiman Roy C., Chief Business Officer

Disposed of 119,677 shares (Tender Offer) ($12M) · Disposed of 170,553 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Chai Christopher Y, Chief Financial Officer

Disposed of 7,101 shares (Tender Offer) ($710K) · Disposed of 318,395 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Goldstein David M, Chief Scientific Officer

Disposed of 31,826 shares (Tender Offer) ($3.18M) · Disposed of 286,117 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 Form 4: Babler Martin, Director

Disposed of 58,557 shares (Tender Offer) ($5.86M) · Disposed of 255 Warrant (Right to Buy) (Disposition to Issuer) · Disposed of 1,047,892 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Sep 2020 S-8 POS
28 Sep 2020 S-8 POS
28 Sep 2020 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support